HK1190432A1 - Method for amplifying nk cells nk - Google Patents
Method for amplifying nk cells nkInfo
- Publication number
- HK1190432A1 HK1190432A1 HK14103574.2A HK14103574A HK1190432A1 HK 1190432 A1 HK1190432 A1 HK 1190432A1 HK 14103574 A HK14103574 A HK 14103574A HK 1190432 A1 HK1190432 A1 HK 1190432A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- amplifying
- cells
- Prior art date
Links
- 210000000822 natural killer cell Anatomy 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0646—Natural killers cells [NK], NKT cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
- A61K39/4613—Natural-killer cells [NK or NK-T]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4643—Vertebrate antigens
- A61K39/4644—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/2302—Interleukin-2 (IL-2)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Cell Biology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Mycology (AREA)
- Developmental Biology & Embryology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2011140725 | 2011-06-24 | ||
JP2012021972A JP5572863B2 (ja) | 2011-06-24 | 2012-02-03 | Nk細胞の増幅方法 |
PCT/JP2012/065718 WO2012176796A1 (ja) | 2011-06-24 | 2012-06-20 | Nk細胞の増幅方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1190432A1 true HK1190432A1 (en) | 2014-07-04 |
Family
ID=47422628
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK14103574.2A HK1190432A1 (en) | 2011-06-24 | 2014-04-14 | Method for amplifying nk cells nk |
Country Status (10)
Country | Link |
---|---|
US (1) | US9404083B2 (xx) |
EP (1) | EP2725100B1 (xx) |
JP (1) | JP5572863B2 (xx) |
KR (1) | KR101963920B1 (xx) |
CN (1) | CN103620022B (xx) |
AU (1) | AU2012274478B2 (xx) |
CA (1) | CA2840161C (xx) |
HK (1) | HK1190432A1 (xx) |
MY (1) | MY161389A (xx) |
WO (1) | WO2012176796A1 (xx) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5511039B1 (ja) * | 2013-05-22 | 2014-06-04 | 国立大学法人九州大学 | Nk細胞の調製方法 |
JP6164650B2 (ja) * | 2014-01-20 | 2017-07-19 | 国立大学法人九州大学 | Nk細胞の調製方法 |
CN106164256B (zh) * | 2014-03-07 | 2021-08-10 | 艾美尔塞勒公司 | 来自脐带血的汇集的nk细胞和在治疗癌和慢性感染病中的应用 |
KR101697473B1 (ko) | 2014-11-26 | 2017-01-18 | 주식회사 녹십자랩셀 | T 세포를 이용한 자연살해세포의 배양방법 |
WO2016122014A1 (ko) * | 2015-01-27 | 2016-08-04 | 한국생명공학연구원 | 자연살해세포의 대량생산 방법 및 상기 방법으로 수득된 자연살해세포의 항암제로서의 용도 |
CN106222141B (zh) * | 2016-10-17 | 2018-10-19 | 湖南丰晖生物科技有限公司 | Nk细胞培养液和细胞培养方法 |
JP6647240B2 (ja) | 2017-05-12 | 2020-02-14 | 米満 吉和 | 高活性nk細胞、およびその利用 |
WO2019152663A1 (en) * | 2018-02-01 | 2019-08-08 | Nkmax Co., Ltd. | Method of producing natural killer cells and composition for treating cancer |
MY197176A (en) | 2018-02-01 | 2023-05-30 | Nkmax Co Ltd | Method of producing natural killer cells and composition for treating cancer |
JP6543375B1 (ja) * | 2018-03-27 | 2019-07-10 | 株式会社ガイアバイオメディシン | ケモカインレセプターと細胞接着分子を発現するcd3陰性細胞の集団、およびその利用 |
CN110628714B (zh) * | 2018-06-21 | 2023-03-28 | 精准生技股份有限公司 | 用于体外扩增自然杀手细胞及自然杀手t细胞的无血清细胞培养液 |
CN109161527A (zh) * | 2018-09-25 | 2019-01-08 | 深圳市五零生命科技有限公司 | 一种高效的nk细胞扩增方法 |
EP3892721A4 (en) * | 2018-11-14 | 2022-08-31 | GC Cell Corporation | METHOD FOR CULTIVATING NATURAL KILLER CELLS DERIVED FROM UMBILICAL CORD BLOOD USING TRANSFORMED T LYMPHOCYTES |
JP6838750B2 (ja) | 2019-01-21 | 2021-03-03 | 株式会社ガイアバイオメディシン | Nk細胞を含む細胞集団の製造方法 |
WO2020152661A1 (ja) | 2019-01-21 | 2020-07-30 | 株式会社ガイアバイオメディシン | Nk細胞を含む細胞集団の製造方法 |
KR102234394B1 (ko) * | 2019-03-08 | 2021-03-31 | 신지섭 | 타가면역세포배양방법, 그 방법으로 얻어진 면역세포배양액 및 이를 포함하는 면역세포치료제 |
KR102216710B1 (ko) * | 2019-03-27 | 2021-02-17 | 신지섭 | Nk세포배양배지용 첨가조성물, 상기 첨가조성물을 이용한 nk세포배양방법 및 상기 배양방법으로 얻어진 피부트러블개선용 화장료조성물 |
CN111154721B (zh) * | 2020-01-14 | 2023-10-17 | 深圳格泰赛尔生物科技有限公司 | Nk细胞扩增方法 |
CN114980907A (zh) * | 2020-01-19 | 2022-08-30 | 得克萨斯大学体系董事会 | 增强细胞癌症治疗的t细胞死亡相关基因8(tdag8)调节 |
JP2024500847A (ja) | 2020-12-18 | 2024-01-10 | センチュリー セラピューティクス,インコーポレイテッド | 適合可能な受容体特異性を有するキメラ抗原受容体システム |
WO2023081813A1 (en) | 2021-11-05 | 2023-05-11 | St. Jude Children's Research Hospital, Inc. | Zip cytokine receptors |
WO2023240182A1 (en) | 2022-06-08 | 2023-12-14 | St. Jude Children's Research Hospital, Inc. | Disruption of kdm4a in t cells to enhance immunotherapy |
WO2024059787A1 (en) | 2022-09-16 | 2024-03-21 | St. Jude Children's Research Hospital, Inc. | Disruption of asxl1 in t cells to enhance immunotherapy |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030068306A1 (en) * | 2001-09-14 | 2003-04-10 | Dilber Mehmet Sirac | Medium |
US7544355B2 (en) * | 2002-03-13 | 2009-06-09 | Universita Degli Studi Di Perugia | Methods and compositions for allogeneic transplantation |
US20080063717A1 (en) | 2002-12-23 | 2008-03-13 | Innate Pharma, S.A.S. | Pharmaceutical Compositions Having an Effect on the Proliferation of Nk Cells and a Method Using the Same |
US7435596B2 (en) | 2004-11-04 | 2008-10-14 | St. Jude Children's Research Hospital, Inc. | Modified cell line and method for expansion of NK cell |
JP5525689B2 (ja) * | 2004-11-02 | 2014-06-18 | ザ ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ アズ リプレゼンティッド バイ ザ セクレタリー デパートメント オブ ヘルス アンド ヒューマン サービシーズ | 過剰増殖性障害を処置するための組成物および方法 |
AU2007223093A1 (en) * | 2006-03-06 | 2007-09-13 | Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Autologous natural killer cells and lymphodepleting chemotherapy for the treatment of cancer |
JP2007297292A (ja) | 2006-04-28 | 2007-11-15 | Kyorin Pharmaceut Co Ltd | 1−アルコキシイソキノリン誘導体又はその水和物の製造方法 |
JP4275680B2 (ja) | 2006-04-28 | 2009-06-10 | 裕 照沼 | リンパ球の活性・増殖に係る培養方法 |
JP2010501173A (ja) | 2006-08-23 | 2010-01-21 | バイネックス カンパニー リミテッド | 免疫治療用活性化リンパ球の製造方法 |
WO2008026381A1 (en) | 2006-08-28 | 2008-03-06 | Hisamitsu Pharmaceutical Co., Inc. | Nail patch |
JP2010220479A (ja) * | 2007-06-15 | 2010-10-07 | Medeinetto:Kk | Nk細胞の培養方法及びnk細胞の利用 |
KR20230065354A (ko) * | 2007-09-28 | 2023-05-11 | 셀룰래리티 인코포레이티드 | 인간 태반 관류액 및 인간 태반-유래 중간체 천연 킬러 세포를 사용한 종양 억제 방법 |
JP5779090B2 (ja) | 2008-04-09 | 2015-09-16 | マックスサイト インコーポレーティッド | 新規に単離された細胞の治療組成物の操作および送達 |
KR101133185B1 (ko) * | 2008-07-29 | 2012-04-06 | 서울대학교병원 | 자연살해세포의 증식방법 |
CN102428173B (zh) * | 2009-03-26 | 2014-07-30 | 细胞维护北欧制药公司 | Nk细胞的扩增 |
CN102597223B (zh) * | 2009-09-11 | 2017-05-10 | 宝生物工程株式会社 | 生产天然杀伤细胞的方法 |
EP3184109B1 (en) | 2009-12-29 | 2020-11-18 | Gamida-Cell Ltd. | Methods for enhancing natural killer cell proliferation and activity |
JP2011239701A (ja) | 2010-05-14 | 2011-12-01 | Tella Inc | 樹状細胞の培養方法 |
KR101039843B1 (ko) | 2010-08-30 | 2011-06-09 | 주식회사 엔케이바이오 | 자기활성화 림프구 배양용 배지 조성물 및 이를 이용한 자기활성화 림프구 배양방법 |
JP5840876B2 (ja) | 2011-06-24 | 2016-01-06 | テラ株式会社 | Nk細胞を増幅するための組成物及び方法 |
-
2012
- 2012-02-03 JP JP2012021972A patent/JP5572863B2/ja active Active
- 2012-06-20 US US14/129,143 patent/US9404083B2/en active Active
- 2012-06-20 EP EP12801859.5A patent/EP2725100B1/en active Active
- 2012-06-20 MY MYPI2013004630A patent/MY161389A/en unknown
- 2012-06-20 WO PCT/JP2012/065718 patent/WO2012176796A1/ja active Application Filing
- 2012-06-20 KR KR1020147001579A patent/KR101963920B1/ko active IP Right Grant
- 2012-06-20 CA CA2840161A patent/CA2840161C/en active Active
- 2012-06-20 AU AU2012274478A patent/AU2012274478B2/en active Active
- 2012-06-20 CN CN201280031188.5A patent/CN103620022B/zh active Active
-
2014
- 2014-04-14 HK HK14103574.2A patent/HK1190432A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
EP2725100A4 (en) | 2015-01-07 |
JP5572863B2 (ja) | 2014-08-20 |
MY161389A (en) | 2017-04-14 |
AU2012274478B2 (en) | 2017-03-30 |
AU2012274478A1 (en) | 2014-02-20 |
US20140120072A1 (en) | 2014-05-01 |
CN103620022B (zh) | 2015-09-30 |
WO2012176796A1 (ja) | 2012-12-27 |
EP2725100A1 (en) | 2014-04-30 |
KR20140051263A (ko) | 2014-04-30 |
KR101963920B1 (ko) | 2019-03-29 |
CN103620022A (zh) | 2014-03-05 |
AU2012274478A8 (en) | 2016-07-28 |
JP2013027385A (ja) | 2013-02-07 |
EP2725100B1 (en) | 2019-09-04 |
CA2840161A1 (en) | 2012-12-27 |
US9404083B2 (en) | 2016-08-02 |
CA2840161C (en) | 2019-02-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1190432A1 (en) | Method for amplifying nk cells nk | |
ZA201307225B (en) | Methods for genomic modification | |
EP2681304A4 (en) | NANOPIPETTES APPARATUS FOR HANDLING CELLS | |
EP2786441A4 (en) | METHOD FOR ALKALIATING ANODES | |
PL3543333T3 (pl) | Sposób badania przesiewowego alfa-amylaz | |
EP2703100A4 (en) | METHOD OF MANUFACTURING FOR A STRETCHED FORGED MATERIAL | |
EP2694642B8 (en) | Method for rejuvenating cells | |
HK1201743A1 (en) | Method for improving executive function | |
IL239056A0 (en) | A method to manipulate T cell helper | |
EP2650276A4 (en) | PROCESS FOR PRODUCTION OF -FLUOROALCOOL | |
EP2832865A4 (en) | METHOD FOR MANUFACTURING MAGNETIC STEEL SHEET ORIENTED | |
ZA201400772B (en) | Method for using vinasse | |
EP2630153A4 (en) | PROCESS FOR PROCESSING INCLUSIVE BODIES | |
HK1207108A1 (en) | Method for obtaining monocytes or nk cells nk | |
LT2872536T (lt) | Biomasės išskyrimo būdas | |
ZA201402881B (en) | Method for processing fischer-tropsch off-gas | |
EP2937406A4 (en) | PROCESS FOR MANUFACTURING BRIQUETTE | |
EP2851974A4 (en) | METHOD FOR PRODUCING A CELL | |
HK1181849A1 (zh) | 用於靶向細胞 選擇的快速方法 | |
ZA201402882B (en) | Method for processing fischer-tropsch off-gas | |
EP2978839A4 (en) | CELL CULTURE METHOD | |
HU1200751D0 (hu) | Eljárás kukorica védelmére | |
HK1197263A1 (en) | System for obtaining biomass | |
PL2776552T3 (pl) | Urządzenie do hodowli komórek | |
GB201322533D0 (en) | Assessment method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
CHRG | Changes in the register |
Free format text: CORRECTION OF THE NAME OF THE APPLICANT FROM "KYUSHU UNIVERSITY" TO "KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION" |